FY2016
Effective from
- First observed
Anaplastic large cell lymphoma, ALK-negative
Category — select a more specific code
CDC/NCHS · FY2016primary cutaneous CD30-positive T-cell proliferations (C86.6-)
personal history of non-Hodgkin lymphoma (Z85.72)
For US diagnosis claims covered by HIPAA, ICD-10-CM is required from October 1, 2015.
Use the service date for outpatient/professional claims and the discharge date for hospital inpatient claims. Earlier encounters use ICD-9-CM; each individual code must also be valid for the applicable date.
Official coding guidelines → · CMS ↗First observed · 2015-10-01
No recorded change since first observation
Effective from
Anaplastic large cell lymphoma, ALK-negative
Category — select a more specific code
CDC/NCHS · FY2016| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
primary cutaneous CD30-positive T-cell proliferations (C86.6-)
personal history of non-Hodgkin lymphoma (Z85.72)
C84.70Anaplastic large cell lymphoma, ALK-negative, unspecified siteBillable / specificC84.71Anaplastic large cell lymphoma, ALK-negative, lymph nodes of head, face, and neckBillable / specificC84.72Anaplastic large cell lymphoma, ALK-negative, intrathoracic lymph nodesBillable / specificC84.73Anaplastic large cell lymphoma, ALK-negative, intra-abdominal lymph nodesBillable / specificC84.74Anaplastic large cell lymphoma, ALK-negative, lymph nodes of axilla and upper limbBillable / specificC84.75Anaplastic large cell lymphoma, ALK-negative, lymph nodes of inguinal region and lower limbBillable / specificC84.76Anaplastic large cell lymphoma, ALK-negative, intrapelvic lymph nodesBillable / specificC84.77Anaplastic large cell lymphoma, ALK-negative, spleenBillable / specificC84.78Anaplastic large cell lymphoma, ALK-negative, lymph nodes of multiple sitesBillable / specificC84.79Anaplastic large cell lymphoma, ALK-negative, extranodal and solid organ sitesBillable / specificC84.7AAnaplastic large cell lymphoma, ALK-negative, breastBillable / specificC84.7BAnaplastic large cell lymphoma, ALK-negative, in remissionBillable / specificOther entries in the same category; these are not automatic substitutes.
| Code | Description | Category · further specificity required |
|---|---|---|
| C84.0 | Mycosis fungoides | Category · further specificity required |
| C84.1 | Sezary disease | Category · further specificity required |
| C84.4 | Peripheral T-cell lymphoma, not elsewhere classified | Category · further specificity required |
| C84.6 | Anaplastic large cell lymphoma, ALK-positive | Category · further specificity required |
| C84.9 | Mature T/NK-cell lymphomas, unspecified | Category · further specificity required |
| C84.A | Cutaneous T-cell lymphoma, unspecified | Category · further specificity required |
| C84.Z | Other mature T/NK-cell lymphomas | Category · further specificity required |
Official titles and instructions are preserved in their source language. Official sources ↗